Cargando…
A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829495/ https://www.ncbi.nlm.nih.gov/pubmed/33495522 http://dx.doi.org/10.1038/s41366-021-00747-z |
_version_ | 1783641179314716672 |
---|---|
author | Kooistra, Emma J. de Nooijer, Aline H. Claassen, Wout J. Grondman, Inge Janssen, Nico A. F. Netea, Mihai G. van de Veerdonk, Frank L. van der Hoeven, Johannes G. Kox, Matthijs Pickkers, Peter |
author_facet | Kooistra, Emma J. de Nooijer, Aline H. Claassen, Wout J. Grondman, Inge Janssen, Nico A. F. Netea, Mihai G. van de Veerdonk, Frank L. van der Hoeven, Johannes G. Kox, Matthijs Pickkers, Peter |
author_sort | Kooistra, Emma J. |
collection | PubMed |
description | BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated with differences in inflammatory, respiratory, and clinical outcome parameters in critically ill COVID-19 patients. SUBJECTS/METHODS: Sixty-seven COVID-19 ICU patients were divided into obese (BMI ≥ 30 kg/m(2), n = 18, 72% class I obesity, 28% class II obesity) and non-obese (BMI < 30 kg/m(2), n = 49) groups. Concentrations of circulating interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interferon gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, and IL-1 receptor antagonist (RA) were determined from ICU admission until 10 days afterward, and routine laboratory and clinical parameters were collected. RESULTS: BMI was 32.6 [31.2–34.5] and 26.0 [24.4–27.7] kg/m(2) in the obese and non-obese group, respectively. Apart from temperature, which was significantly lower in obese patients (38.1 [36.9–38.9] vs. 38.7 [38.0 −39.5] °C, p = 0.02), there were no between-group differences on ICU admission. Plasma cytokine concentrations declined over time (p < 0.05 for all), but no differences between obese and non-obese patients were observed. Also, BMI did not correlate with the cytokine response (IL-6 r = 0.09, p = 0.61, TNF-α r = 0.03, p = 0.99, IP-10 r = 0.28, p = 0.11). The kinetics of clinical inflammatory parameters and respiratory mechanics were also similar in both groups. Finally, no differences in time on ventilator, ICU length of stay or 40-day mortality between obese and non-obese patients were apparent. CONCLUSIONS: In COVID-19 patients requiring mechanical ventilation in the ICU, a higher BMI is not related to a different immunological response, unfavorable respiratory mechanics, or impaired outcome. |
format | Online Article Text |
id | pubmed-7829495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78294952021-01-25 A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients Kooistra, Emma J. de Nooijer, Aline H. Claassen, Wout J. Grondman, Inge Janssen, Nico A. F. Netea, Mihai G. van de Veerdonk, Frank L. van der Hoeven, Johannes G. Kox, Matthijs Pickkers, Peter Int J Obes (Lond) Article BACKGROUND/OBJECTIVES: Obesity appears to be an independent risk factor for ICU admission and a severe disease course in COVID-19 patients. An aberrant inflammatory response and impaired respiratory function have been suggested as underlying mechanisms. We investigated whether obesity is associated with differences in inflammatory, respiratory, and clinical outcome parameters in critically ill COVID-19 patients. SUBJECTS/METHODS: Sixty-seven COVID-19 ICU patients were divided into obese (BMI ≥ 30 kg/m(2), n = 18, 72% class I obesity, 28% class II obesity) and non-obese (BMI < 30 kg/m(2), n = 49) groups. Concentrations of circulating interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interferon gamma-induced protein (IP)-10, monocyte chemoattractant protein (MCP)-1, and IL-1 receptor antagonist (RA) were determined from ICU admission until 10 days afterward, and routine laboratory and clinical parameters were collected. RESULTS: BMI was 32.6 [31.2–34.5] and 26.0 [24.4–27.7] kg/m(2) in the obese and non-obese group, respectively. Apart from temperature, which was significantly lower in obese patients (38.1 [36.9–38.9] vs. 38.7 [38.0 −39.5] °C, p = 0.02), there were no between-group differences on ICU admission. Plasma cytokine concentrations declined over time (p < 0.05 for all), but no differences between obese and non-obese patients were observed. Also, BMI did not correlate with the cytokine response (IL-6 r = 0.09, p = 0.61, TNF-α r = 0.03, p = 0.99, IP-10 r = 0.28, p = 0.11). The kinetics of clinical inflammatory parameters and respiratory mechanics were also similar in both groups. Finally, no differences in time on ventilator, ICU length of stay or 40-day mortality between obese and non-obese patients were apparent. CONCLUSIONS: In COVID-19 patients requiring mechanical ventilation in the ICU, a higher BMI is not related to a different immunological response, unfavorable respiratory mechanics, or impaired outcome. Nature Publishing Group UK 2021-01-25 2021 /pmc/articles/PMC7829495/ /pubmed/33495522 http://dx.doi.org/10.1038/s41366-021-00747-z Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Kooistra, Emma J. de Nooijer, Aline H. Claassen, Wout J. Grondman, Inge Janssen, Nico A. F. Netea, Mihai G. van de Veerdonk, Frank L. van der Hoeven, Johannes G. Kox, Matthijs Pickkers, Peter A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title | A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title_full | A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title_fullStr | A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title_full_unstemmed | A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title_short | A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients |
title_sort | higher bmi is not associated with a different immune response and disease course in critically ill covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829495/ https://www.ncbi.nlm.nih.gov/pubmed/33495522 http://dx.doi.org/10.1038/s41366-021-00747-z |
work_keys_str_mv | AT kooistraemmaj ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT denooijeralineh ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT claassenwoutj ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT grondmaninge ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT janssennicoaf ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT neteamihaig ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT vandeveerdonkfrankl ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT vanderhoevenjohannesg ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT koxmatthijs ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT pickkerspeter ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT ahigherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT kooistraemmaj higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT denooijeralineh higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT claassenwoutj higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT grondmaninge higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT janssennicoaf higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT neteamihaig higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT vandeveerdonkfrankl higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT vanderhoevenjohannesg higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT koxmatthijs higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT pickkerspeter higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients AT higherbmiisnotassociatedwithadifferentimmuneresponseanddiseasecourseincriticallyillcovid19patients |